Get Premium to unlock powerful stock data
Vir Biotechnology Inc logo

Vir Biotechnology Inc

$ 24.90 +2.185 (+9.62%) 02:12 PM EST
P/E:
2.82
P/B:
1.67
Market Cap:
$ 3.31B
Enterprise V:
$ 1.88B
Volume:
555.82K
Avg Vol (2M):
1.91M
Also Trade In:
Volume:
555.82K
Market Cap $:
3.31B
PE Ratio:
2.82
Avg Vol (2-Month):
1.91M
Enterprise Value $:
1.88B
PB Ratio:
1.67
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Vir Biotechnology Inc
NAICS : 325412 SIC : 2834
499 Illinois Street, Suite 500, San Francisco, CA, USA, 94158
Description
Vir Biotechnology Inc is a commercial-stage immunology company focused on treating and preventing infectious diseases. It has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA, through internal development, collaborations, and acquisitions. The company's pipeline consists of product candidates targeting hepatitis B virus, or HBV, influenza A, human immunodeficiency virus, or HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue and license revenue.
Name Current Vs Industry Vs History
Cash-To-Debt 9.21
Equity-to-Asset 0.69
Debt-to-Equity 0.07
Debt-to-EBITDA 0.09
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 5.67
Distress
Grey
Safe
Beneish M-Score 28.61
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 867.4
3-Year FCF Growth Rate 21

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 58.95
9-Day RSI 54.99
14-Day RSI 52.08
6-1 Month Momentum % -27.36
12-1 Month Momentum % -47.88

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.66
Quick Ratio 3.66
Cash Ratio 1.79
Days Payable 17.05

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -10.6

Financials (Next Earnings Date:2022-08-05 Est.)

VIR's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:VIR

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Performance
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 2,316.393
EPS (TTM) ($) 9.05
Beta 0
Volatility % 74.2
14-Day RSI 52.08
14-Day ATR ($) 1.686387
20-Day SMA ($) 21.578
12-1 Month Momentum % -47.88
52-Week Range ($) 18.21 - 58
Shares Outstanding (Mil) 132.38

Piotroski F-Score Details

Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Vir Biotechnology Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More